Published in Vaccine on October 01, 2003
Genome plasticity of BCG and impact on vaccine efficacy. Proc Natl Acad Sci U S A (2007) 3.73
Novel genetic polymorphisms that further delineate the phylogeny of the Mycobacterium tuberculosis complex. J Bacteriol (2006) 2.55
Genomic analysis distinguishes Mycobacterium africanum. J Clin Microbiol (2004) 2.01
Extensive genomic polymorphism within Mycobacterium avium. J Bacteriol (2004) 1.61
Genomic analysis of a mycobacterium bovis bacillus [corrected] Calmette-Guérin strain isolated from an adult patient with pulmonary tuberculosis.. PLoS One (2015) 1.43
Molecular detection of Mycobacterium bovis and Mycobacterium bovis BCG (Pasteur) in soil. Appl Environ Microbiol (2005) 1.42
Revisiting the evolution of Mycobacterium bovis. J Bacteriol (2005) 1.39
Identification of mycobacterial sigma factor binding sites by chromatin immunoprecipitation assays. J Bacteriol (2006) 1.33
Mycobacterium tuberculosis H37Rv: Delta RD1 is more virulent than M. bovis bacille Calmette-Guérin in long-term murine infection. J Infect Dis (2004) 1.27
Genomic interrogation of the dassie bacillus reveals it as a unique RD1 mutant within the Mycobacterium tuberculosis complex. J Bacteriol (2004) 1.25
Novel genome polymorphisms in BCG vaccine strains and impact on efficacy. BMC Genomics (2008) 1.19
Perspectives on clinical and preclinical testing of new tuberculosis vaccines. Clin Microbiol Rev (2010) 1.13
Defining pathogenic bacterial species in the genomic era. Front Microbiol (2011) 1.02
Genome sequence of Mycobacterium bovis BCG Moreau, the Brazilian vaccine strain against tuberculosis. J Bacteriol (2011) 1.00
Tuberculosis vaccine strain Mycobacterium bovis BCG Russia is a natural recA mutant. BMC Microbiol (2008) 0.98
Reducing the activity and secretion of microbial antioxidants enhances the immunogenicity of BCG. PLoS One (2009) 0.97
Impact of methoxymycolic acid production by Mycobacterium bovis BCG vaccines. Infect Immun (2004) 0.97
Immune response induced by three Mycobacterium bovis BCG substrains with diverse regions of deletion in a C57BL/6 mouse model. Clin Vaccine Immunol (2008) 0.95
Recurrent tuberculosis: relapse, reinfection, and HIV. J Infect Dis (2010) 0.90
BCG vaccine in Korea. Clin Exp Vaccine Res (2013) 0.89
Region of difference 2 contributes to virulence of Mycobacterium tuberculosis. Infect Immun (2010) 0.86
Novel multiplex PCR using dual-priming oligonucleotides for detection and discrimination of the Mycobacterium tuberculosis complex and M. bovis BCG. J Clin Microbiol (2010) 0.85
Strain-specific differences in the genetic control of two closely related mycobacteria. PLoS Pathog (2010) 0.84
A point mutation in cycA partially contributes to the D-cycloserine resistance trait of Mycobacterium bovis BCG vaccine strains. PLoS One (2012) 0.84
Population genomics of Mycobacterium tuberculosis in the Inuit. Proc Natl Acad Sci U S A (2015) 0.83
Joint effects of host genetic background and mycobacterial pathogen on susceptibility to infection. Infect Immun (2011) 0.81
BCG sub-strains induce variable protection against virulent pulmonary Mycobacterium tuberculosis infection, with the capacity to drive Th2 immunity. Vaccine (2011) 0.79
Strain-dependent variation in Mycobacterium bovis BCG-induced human T-cell activation and gamma interferon production in vitro. Infect Immun (2007) 0.79
Complete Genome Sequence of Mycobacterium bovis Strain BCG-1 (Russia). Genome Announc (2016) 0.78
Modulation of humoral immune response to oral BCG vaccination by Mycobacterium bovis BCG Moreau Rio de Janeiro (RDJ) in healthy adults. J Immune Based Ther Vaccines (2006) 0.78
The Impact of Genome Region of Difference 4 (RD4) on Mycobacterial Virulence and BCG Efficacy. Front Cell Infect Microbiol (2017) 0.75
Variable host-pathogen compatibility in Mycobacterium tuberculosis. Proc Natl Acad Sci U S A (2006) 8.90
Global phylogeography of Mycobacterium tuberculosis and implications for tuberculosis product development. Lancet Infect Dis (2007) 6.45
The competitive cost of antibiotic resistance in Mycobacterium tuberculosis. Science (2006) 5.41
Deletion of RD1 from Mycobacterium tuberculosis mimics bacille Calmette-Guérin attenuation. J Infect Dis (2002) 5.15
Stable association between strains of Mycobacterium tuberculosis and their human host populations. Proc Natl Acad Sci U S A (2004) 4.98
Rate of reinfection tuberculosis after successful treatment is higher than rate of new tuberculosis. Am J Respir Crit Care Med (2005) 4.94
Human T cell epitopes of Mycobacterium tuberculosis are evolutionarily hyperconserved. Nat Genet (2010) 4.94
Functional and evolutionary genomics of Mycobacterium tuberculosis: insights from genomic deletions in 100 strains. Proc Natl Acad Sci U S A (2004) 4.78
High functional diversity in Mycobacterium tuberculosis driven by genetic drift and human demography. PLoS Biol (2008) 4.74
Genome plasticity of BCG and impact on vaccine efficacy. Proc Natl Acad Sci U S A (2007) 3.73
Genomic deletions classify the Beijing/W strains as a distinct genetic lineage of Mycobacterium tuberculosis. J Clin Microbiol (2005) 3.67
Proportion of tuberculosis transmission that takes place in households in a high-incidence area. Lancet (2004) 3.65
Effect of drug resistance on the generation of secondary cases of tuberculosis. J Infect Dis (2003) 3.27
Progression to active tuberculosis, but not transmission, varies by Mycobacterium tuberculosis lineage in The Gambia. J Infect Dis (2008) 3.15
Tuberculosis diagnosis--time for a game change. N Engl J Med (2010) 2.96
Does DOTS work in populations with drug-resistant tuberculosis? Lancet (2005) 2.95
Genomic deletions suggest a phylogeny for the Mycobacterium tuberculosis complex. J Infect Dis (2002) 2.85
Tuberculosis and diabetes in southern Mexico. Diabetes Care (2004) 2.83
Mycobacterium avium in the postgenomic era. Clin Microbiol Rev (2007) 2.65
Transmission of tuberculosis in a high incidence urban community in South Africa. Int J Epidemiol (2004) 2.62
The W-Beijing lineage of Mycobacterium tuberculosis overproduces triglycerides and has the DosR dormancy regulon constitutively upregulated. J Bacteriol (2007) 2.42
NOD2, RIP2 and IRF5 play a critical role in the type I interferon response to Mycobacterium tuberculosis. PLoS Pathog (2009) 2.31
Impact of bacterial genetics on the transmission of isoniazid-resistant Mycobacterium tuberculosis. PLoS Pathog (2006) 2.26
The BCG World Atlas: a database of global BCG vaccination policies and practices. PLoS Med (2011) 1.95
Major Mycobacterium tuberculosis lineages associate with patient country of origin. J Clin Microbiol (2009) 1.91
T-cell assays for tuberculosis infection: deriving cut-offs for conversions using reproducibility data. PLoS One (2008) 1.91
NOD2-deficient mice have impaired resistance to Mycobacterium tuberculosis infection through defective innate and adaptive immunity. J Immunol (2008) 1.73
Increased NOD2-mediated recognition of N-glycolyl muramyl dipeptide. J Exp Med (2009) 1.68
Direct and indirect induction by 1,25-dihydroxyvitamin D3 of the NOD2/CARD15-defensin beta2 innate immune pathway defective in Crohn disease. J Biol Chem (2009) 1.68
Extraction of Mycobacterium tuberculosis DNA: a question of containment. J Clin Microbiol (2005) 1.65
Comparative metagenomic study of alterations to the intestinal microbiota and risk of nosocomial Clostridum difficile-associated disease. J Infect Dis (2010) 1.62
Extensive genomic polymorphism within Mycobacterium avium. J Bacteriol (2004) 1.61
Mycobacterium africanum elicits an attenuated T cell response to early secreted antigenic target, 6 kDa, in patients with tuberculosis and their household contacts. J Infect Dis (2006) 1.56
Sensitivities and specificities of spoligotyping and mycobacterial interspersed repetitive unit-variable-number tandem repeat typing methods for studying molecular epidemiology of tuberculosis. J Clin Microbiol (2005) 1.54
Sequencing of hsp65 distinguishes among subsets of the Mycobacterium avium complex. J Clin Microbiol (2006) 1.47
Mycobacterium avium subsp. paratuberculosis and M. avium subsp. avium are independently evolved pathogenic clones of a much broader group of M. avium organisms. J Bacteriol (2008) 1.46
Genomic polymorphisms for Mycobacterium avium subsp. paratuberculosis diagnostics. J Clin Microbiol (2005) 1.45
High rates of recombination in otitis media isolates of non-typeable Haemophilus influenzae. Infect Genet Evol (2003) 1.45
Deletion-targeted multiplex PCR (DTM-PCR) for identification of Beijing/W genotypes of Mycobacterium tuberculosis. Tuberculosis (Edinb) (2007) 1.44
Revisiting the evolution of Mycobacterium bovis. J Bacteriol (2005) 1.39
Genomic interrogation of ancestral Mycobacterium tuberculosis from south India. Infect Genet Evol (2007) 1.37
Tuberculosis due to multiple strains: a concern for the patient? A concern for tuberculosis control? Am J Respir Crit Care Med (2004) 1.37
Transmission of drug-resistant tuberculosis among treated patients in Shanghai, China. J Infect Dis (2007) 1.36
Gene expression diversity among Mycobacterium tuberculosis clinical isolates. Microbiology (2005) 1.36
Differentiating host-associated variants of Mycobacterium avium by PCR for detection of large sequence polymorphisms. J Clin Microbiol (2006) 1.29
Reduced expression of antigenic proteins MPB70 and MPB83 in Mycobacterium bovis BCG strains due to a start codon mutation in sigK. Mol Microbiol (2005) 1.29
Reductions in intestinal Clostridiales precede the development of nosocomial Clostridium difficile infection. Microbiome (2013) 1.26
Estimating change rates of genetic markers using serial samples: applications to the transposon IS6110 in Mycobacterium tuberculosis. Theor Popul Biol (2003) 1.26
Genomic interrogation of the dassie bacillus reveals it as a unique RD1 mutant within the Mycobacterium tuberculosis complex. J Bacteriol (2004) 1.25
Mycobacterium tuberculosis: immune evasion, latency and reactivation. Immunobiology (2011) 1.25
Genotyping of Mycobacterium avium complex organisms using multispacer sequence typing. Microbiology (2009) 1.24
High-throughput method for detecting genomic-deletion polymorphisms. J Clin Microbiol (2004) 1.21
The two-component regulatory system mtrAB is required for morphotypic multidrug resistance in Mycobacterium avium. Antimicrob Agents Chemother (2006) 1.21
Insertion and deletion events that define the pathogen Mycobacterium avium subsp. paratuberculosis. J Bacteriol (2008) 1.18
Isolation of the genome sequence strain Mycobacterium avium 104 from multiple patients over a 17-year period. J Clin Microbiol (2006) 1.17
Mycobacterium bovis BCG vaccines exhibit defects in alanine and serine catabolism. Infect Immun (2003) 1.14
Rapid identification and susceptibility testing of Mycobacterium tuberculosis from MGIT cultures with luciferase reporter mycobacteriophages. J Med Microbiol (2003) 1.13
Mycobacterium africanum: a new opportunistic pathogen in HIV infection? AIDS (2005) 1.13
Mutations in Mycobacterium tuberculosis Rv0444c, the gene encoding anti-SigK, explain high level expression of MPB70 and MPB83 in Mycobacterium bovis. Mol Microbiol (2006) 1.13
Does resistance to pyrazinamide accurately indicate the presence of Mycobacterium bovis? J Clin Microbiol (2005) 1.11
Reduced transmissibility of East African Indian strains of Mycobacterium tuberculosis. PLoS One (2011) 1.11
Point mutations in the DNA- and cNMP-binding domains of the homologue of the cAMP receptor protein (CRP) in Mycobacterium bovis BCG: implications for the inactivation of a global regulator and strain attenuation. Microbiology (2005) 1.10
Clinical management of tuberculosis in the context of HIV infection. Annu Rev Med (2004) 1.09
The Mycobacterium tuberculosis complex transcriptome of attenuation. Tuberculosis (Edinb) (2004) 1.08
Tuberculosis in the Inuit community of Quebec, Canada. Am J Respir Crit Care Med (2003) 1.07
The non-classical functions of the classical complement pathway recognition subcomponent C1q. Immunol Lett (2010) 1.07
Widespread pyrazinamide-resistant Mycobacterium tuberculosis family in a low-incidence setting. J Clin Microbiol (2003) 1.06
Repeat IGRA testing in Canadian health workers: conversions or unexplained variability? PLoS One (2013) 1.05
Phylogenetic detection of horizontal gene transfer during the step-wise genesis of Mycobacterium tuberculosis. BMC Evol Biol (2009) 1.04
The origin and evolution of Mycobacterium tuberculosis. Clin Chest Med (2005) 1.03
Evaluation of in situ methods used to detect Mycobacterium avium subsp. paratuberculosis in samples from patients with Crohn's disease. J Clin Microbiol (2006) 1.02
Vitamin D induces interleukin-1β expression: paracrine macrophage epithelial signaling controls M. tuberculosis infection. PLoS Pathog (2013) 1.02
Inter- and intra-subtype genotypic differences that differentiate Mycobacterium avium subspecies paratuberculosis strains. BMC Microbiol (2012) 1.01
Tuberculosis vaccine trials. Lancet (2013) 1.00
Hypoxia induces an immunodominant target of tuberculosis specific T cells absent from common BCG vaccines. PLoS Pathog (2010) 0.99
Tuberculosis in ageing: high rates, complex diagnosis and poor clinical outcomes. Age Ageing (2012) 0.97
Impact of methoxymycolic acid production by Mycobacterium bovis BCG vaccines. Infect Immun (2004) 0.97
Determining the genomic locations of repetitive DNA sequences with a whole-genome microarray: IS6110 in Mycobacterium tuberculosis. J Clin Microbiol (2002) 0.96
The control of copy number of IS6110 in Mycobacterium tuberculosis. Mol Biol Evol (2004) 0.96
Dispersal of Mycobacterium tuberculosis via the Canadian fur trade. Proc Natl Acad Sci U S A (2011) 0.95
Genetic characterization of the Guinea-Bissau family of Mycobacterium tuberculosis complex strains. Microbes Infect (2004) 0.95
The rise and fall of the Mycobacterium tuberculosis genome. Trends Microbiol (2011) 0.94
Insertion sequence IS900 revisited. J Clin Microbiol (2006) 0.94
TB screening in Canadian health care workers using interferon-gamma release assays. PLoS One (2012) 0.93
Partnering for better microbial diagnostics. Nat Biotechnol (2006) 0.93
Evaluation of a semi-automated reporter phage assay for susceptibility testing of Mycobacterium tuberculosis isolates in South Africa. Tuberculosis (Edinb) (2007) 0.92
Antimycobacterial therapy for Crohn's disease: a reanalysis. Lancet Infect Dis (2008) 0.92
Crohn's as an immune deficiency: from apparent paradox to evolving paradigm. Expert Rev Clin Immunol (2013) 0.91
Admitting defeat. Int J Tuberc Lung Dis (2006) 0.90
Bayesian modelling of tuberculosis clustering from DNA fingerprint data. Stat Med (2008) 0.90
Scratching the surface of ignorance on MDR tuberculosis. Lancet (2009) 0.89
Autoinducer-2 triggers the oxidative stress response in Mycobacterium avium, leading to biofilm formation. Appl Environ Microbiol (2008) 0.89
Mycobacteria in Crohn's disease: how innate immune deficiency may result in chronic inflammation. Expert Rev Clin Immunol (2010) 0.89
Microevolution of the direct repeat locus of Mycobacterium tuberculosis in a strain prevalent in San Francisco. J Clin Microbiol (2006) 0.89
Use of rapid genomic deletion typing to monitor a tuberculosis outbreak within an urban homeless population. J Clin Microbiol (2005) 0.89
Mycobacterial virulence and specialized secretion: same story, different ending. Nat Med (2007) 0.88
Visualization of Mycobacterium avium in Crohn's tissue by oil-immersion microscopy. Microbes Infect (2007) 0.88
How close is close enough? Exploring matching criteria in the estimation of recent transmission of tuberculosis. Am J Epidemiol (2010) 0.88